Fig. 6From: Cutaneous neurofibromas: patients’ medical burden, current management and therapeutic expectations: results from an online European patient community surveyRisk benefit balance depending on the cNF severity. Presentation of the risk benefit balance globally and by cNF severity grade expressed as the % of patients who preferred a moderately effective but well tolerated treatment compared to a highly effective treatment with some side effectsBack to article page